EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated

Sarah Pike, Chen-Ching Peng, Paolo Neviani, Jesse L Berry, Liya Xu

Investigative Opthalmology & Visual Science · 2023

DOI: 10.1167/iovs.64.10.5 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Sarah Pike and 4 co-authors. Institution: The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States. Major MEDLINE topics: Retinoblastoma, Extracellular Vesicles, Retinal Neoplasms. Cited 16 times so far (Crossref); 63 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCI NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Although biopsy is contraindicated in retinoblastoma (RB), the aqueous humor (AH) is a robust liquid biopsy source of molecular tumor information, facilitating biomarker discovery. Small extracellular vesicles (sEVs), promising biomarker candidates across multiple cancers, were recently identified in RB AH, but relationships between sEVs and RB clinical features are unknown.

Methods

We analyzed sEVs in 37 AH samples from 18 RB eyes of varying International Intraocular Retinoblastoma Classification (IIRC) groups and explored clinical correlations. Ten samples were collected at diagnosis (DX) and 27 during treatment (Tx). Unprocessed AH underwent Single Particle-Interferometric Reflectance Imaging Sensor (SP-IRIS) analysis for fluorescent particle count and tetraspanin immunophenotyping; counts were subsequentially converted to percentages for analysis.

Results

Comparing DX and Tx samples, a higher percentage of CD63/81+ sEVs was found in DX AH (16.3 ± 11.6% vs. 5.49 ± 3.67% P = 0.0009), with a more homogenous mono-CD63+ sEV population seen in Tx AH (43.5 ± 14.7% vs. 28.8 ± 9.38%, P = 0.0073). Among DX samples, CD63/81+ sEVs were most abundant in group E eyes (n = 2) compared to group D (n = 6) by count (2.75 × 105 ± 3.40 × 105 vs. 5.95 × 103 ± 8.16 × 103, P = 0.0006), and to group A + B (n = 2) by count (2.75 × 105 ± 3.40 × 105 vs. 2.73 × 102 ± 2.59 × 102, P = 0.0096) and percentage (32.1 ± 7.98% vs. 7.79 ± 0.02%, P = 0.0187).

Conclusions

CD63/81+ sEVs enrich AH from RB eyes before treatment and those with more significant tumor burden, suggesting they are tumor-derived. Future research into their cargo may reveal mechanisms of cellular communication via sEVs in RB and novel biomarkers.

Subjects

MeSH terms (MEDLINE)

RetinoblastomaExtracellular VesiclesRetinal NeoplasmsHumansAqueous HumorBiomarkersTetraspanin 30

Substances

BiomarkersCD63 protein, humanTetraspanin 30

Authors and institutions

  • The Vision Center, Children's Hospital Los Angeles, Los Angeles, California, United States.
  • USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States.
  • Extracellular Vesicle Core, Children's Hospital Los Angeles, Los Angeles, California, United States.
  • The Saban Research Institute, Children's Hospital Los Angeles, Los Angeles, California, United States.
  • Norris Comprehensive Cancer Center, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States.

Funding

  • NCI NIH HHS

Cite

APA

Pike, S., Peng, C. C., Neviani, P., Berry, J. L., & Xu, L. (2023). CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.10.5

Vancouver

Pike S, Peng CC, Neviani P, Berry JL, Xu L. CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.10.5

BibTeX
@article{Pike2023,
  author = {Pike, Sarah and Peng, Chen-Ching and Neviani, Paolo and Berry, Jesse L and Xu, Liya},
  title = {CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  doi = {10.1167/iovs.64.10.5}
}
Start for free →